Cytokine Profiling in Cerebrospinal Fluid of Patients with Newly Diagnosed Relapsing-Remitting Multiple Sclerosis (RRMS): Associations between Inflammatory Biomarkers and Disease Activity
Open Access
- 5 July 2024
- journal article
- research article
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 25 (13) , 7399
Abstract
Cytokines regulate immune responses and are crucial to MS pathogenesis. This study evaluated pro-inflammatory and anti-inflammatory cytokine concentrations in the CSF of de novo diagnosed RRMS patients compared to healthy controls. We assessed cytokine levels in the CSF of 118 de novo diagnosed RRMS patients and 112 controls, analyzing relationships with time from symptom onset to diagnosis, MRI lesions, and serum vitamin D levels. Elevated levels of IL-2, IL-4, IL-6, IL-13, FGF-basic, and GM-CSF, and lower levels of IL-1β, IL-1RA, IL-5, IL-7, IL-9, IL-10, IL-12p70, IL-15, G-CSF, PDGF-bb, and VEGF were observed in RRMS patients compared to controls. IL-2, IL-4, IL-12p70, PDGF, G-CSF, GM-CSF, and FGF-basic levels increased over time, while IL-10 decreased. IL-1β, IL-1RA, IL-6, TNF-α, and PDGF-bb levels negatively correlated with serum vitamin D. TNF-α levels positively correlated with post-contrast-enhancing brain lesions. IL-15 levels negatively correlated with T2 and Gd(+) lesions in C-spine MRI, while TNF-α, PDGF-bb, and FGF-basic correlated positively with T2 lesions in C-spine MRI. IL-6 levels positively correlated with post-contrast-enhancing lesions in Th-spine MRI. Distinct cytokine profiles in the CSF of de novo diagnosed MS patients provide insights into MS pathogenesis and guide immunomodulatory therapy strategies.Keywords
Funding Information
- Medical University of Silesia in Katowice
This publication has 51 references indexed in Scilit:
- The Properties of Cytokines in Multiple Sclerosis: Pros and ConsThe American Journal of the Medical Sciences, 2018
- Allergic diseases: From bench to clinic - Contribution of the discovery of interleukin-5Cytokine, 2017
- An update on immunopathogenesis, diagnosis, and treatment of multiple sclerosisBrain and Behavior, 2015
- Multiple sclerosis in the Arabian Gulf countries: a consensus statementJournal of Neurology, 2013
- Interleukin‐1β causes synaptic hyperexcitability in multiple sclerosisAnnals of Neurology, 2011
- The interleukin‐7 receptor α chain contributes to altered homeostasis of regulatory T cells in multiple sclerosisEuropean Journal of Immunology, 2010
- IL‐10 suppressor activity and ex vivo Tr1 cell function are impaired in multiple sclerosisEuropean Journal of Immunology, 2008
- Correlations between IL-4, IL-12 levels and CCL2, CCL5 levels in serum and cerebrospinal fluid of multiple sclerosis patientsJournal of Neural Transmission, 2004
- Cytokines and the immune responseBiotherapy, 1996
- Interleukin-2, soluble interleukin-2-receptor, neopterin,l-tryptophan and ?2-microglobulin levels in CSF and serum of patients with relapsing-remitting or chronic-progressive multiple sclerosisJournal of Neurology, 1993